Multicenter vs single center Phase II evaluation of 4’-iodo-4’-deoxydoxorubicin in advanced breast cancer
- 1 November 1991
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 2 (10) , 703-706
- https://doi.org/10.1093/oxfordjournals.annonc.a057845
Abstract
G. Schwartsmann, MD PhD, H. M. Pinedo, MD PhD; Multicenter vs single center Phase II evaluation of 4'-iodo-4'-deoxydoxorubicin in advanced breast cancer, AnnalKeywords
This publication has 12 references indexed in Scilit:
- Phase II studies of 4’-iodo-4’-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancersAnnals of Oncology, 1991
- Activity and toxicity of 4’-iodo-4’-deoxydoxorubicin in patients with advanced breast cancerAnnals of Oncology, 1991
- Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of eastern cooperative group and cancer and leukemia group B studiesCancer, 1990
- Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies?Breast Cancer Research and Treatment, 1989
- The main steps in the development of anticancer agentsRadiotherapy and Oncology, 1988
- Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081Cancer, 1988
- A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinomaBritish Journal of Cancer, 1987
- Clinical trials in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Quality of Institutional Participation in Multicenter Clinical TrialsNew England Journal of Medicine, 1981
- Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapyCancer, 1980